What is Seaport Res Ptn’s Forecast for Curaleaf Q4 Earnings?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Analysts at Seaport Res Ptn dropped their Q4 2024 EPS estimates for shares of Curaleaf in a report released on Sunday, November 17th. Seaport Res Ptn analyst S. Randhawa now expects that the company will post earnings of ($0.08) per share for the quarter, down from their prior estimate of ($0.06). The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Seaport Res Ptn also issued estimates for Curaleaf’s Q1 2025 earnings at ($0.06) EPS, Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.05) EPS and FY2025 earnings at ($0.21) EPS.

A number of other equities research analysts have also issued reports on the company. Needham & Company LLC reaffirmed a “buy” rating and set a $6.25 target price on shares of Curaleaf in a research report on Thursday, August 8th. Roth Capital raised shares of Curaleaf to a “strong-buy” rating in a research report on Sunday, November 10th. Finally, Cormark lowered Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday, November 7th.

Curaleaf Price Performance

Shares of OTCMKTS:CURLF opened at $2.10 on Wednesday. The stock’s 50 day moving average price is $2.84 and its 200 day moving average price is $3.61. The stock has a market cap of $1.36 billion, a price-to-earnings ratio of -7.22 and a beta of 0.86. Curaleaf has a 12 month low of $1.64 and a 12 month high of $6.40. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.11 and a quick ratio of 0.51.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.